🇺🇸 FDA
Patent

US 8357718

Compounds and methods for the treatment or prevention of flavivirus infections

granted A61KA61K31/381A61K31/4535

Quick answer

US patent 8357718 (Compounds and methods for the treatment or prevention of flavivirus infections) held by Vertex Pharmaceuticals (Canada) Incorporated expires Mon Jan 17 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Vertex Pharmaceuticals (Canada) Incorporated
Grant date
Tue Jan 22 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 17 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
5
CPC classes
A61K, A61K31/381, A61K31/4535, A61K31/55, A61K45/00